Receptor inhibition by immunoglobulins: specific inhibition by autistic children, their relatives, and control subjects.
Receptor inhibition by immunoglobulins: specific inhibition by autistic children, their relatives, and control subjects.
复制标题
免疫球蛋白的受体抑制:自闭症儿童、其亲属和对照受试者的特异性抑制。
DOI:
10.1007/bf01066419
复制
发表时间:
1993
影响因子:
3.9
通讯作者:
Leventhal,BL
中科院分区:
文献类型:
--
作者:
CookJr,EH;Perry,BD;Dawson,G;Wainwright,MS;Leventhal,BL
Forty-two parents of children with autistic disorder, 15 children with autistic disorder, 17 siblings of children with autistic disorder, and 12 unrelated normal adult controls were studied to determine if immunoglobulins isolated from their plasma would inhibit binding of the 5HT1Aagonist, [3H]-8-hydroxy-N,N-dipropyl-2-aminotetralin (DPAT) to 5HT1Areceptors in human hippocampal membranes. There were no significant differences among the means of percentage inhibition of DPAT binding of parents, children with autistic disorder, siblings, or unrelated controls. In addition, there were no differences in the proportion of subjects with >15% DPAT inhibition among autistic children, their parents, their siblings, or unrelated controls. Immunoglobulin inhibition was not specific for the 5HT1Areceptor binding site, since immunoglobulins inhibited binding to 5HT2, D1, D2, and α2-adrenergic binding sites. The immunoglobulins isolated from normal controls inhibited [3H]-rauwolscine binding at α2-adrenergic sites less than immunoglobulins of children with autistic disorder and their parents and siblings. This study did not support the hypothesis that autoantibodies to 5HT1Aor 5HT2receptors are characteristic of autistic disorder.